Regeneron Receives FDA Priority Review for EYLEA HD's Expanded Dosing Options in Treating Retinal Vein Occlusion
"This could change everything for RVO patients!"
"How does the dosing compare to other treatments?"
"Impressive results in the QUASAR trial!"
"I'm concerned about the safety profile, though."
"Can't wait to see the final approval in August!"
"So glad to hear about fewer injections needed!"
"Is there a timeline for availability if approved?"
"Regeneron is doing amazing work in eye care."
"I hope insurance covers this treatment!"
"What are the side effects we should be aware of?"
2025-04-17T11:00:00.000Z
Hans Schneider
Source of the news: www.globenewswire.com